MannKind Corp (NASDAQ:MNKD)
| 2.01 BATS BZX Real-Time Price As of 11:21am ET |  +0.005 / +0.25%Today’s Change | 0.80 Today|||52-Week Range 2.48 | +55.81% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $469.8M |
Company Description
MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.
Contact Information
MannKind Corp. 30930 Russell Ranch Road Westlake Village California 91362 |
Employees
Shareholders
| Individual stakeholders | 4.11% |
| Mutual fund holders | 16.39% |
| Other institutional | 14.60% |
Top Executives
| Michael E. Castagna | Chief Executive Officer & Director |
| Steven Binder | CFO & Principal Accounting Officer |
| Joseph Kocinsky | Chief Technology Officer |
| Kevin Kaiserman | Vice President-Medical Affairs & Safety |
| David B. Thomson | Secretary, Vice President & General Counsel |
